Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Sonnet BioTherapeutics Holdings, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | 457 | (c) | 11,597,947 | $ | 0.2256 | (2) | $ | 2,616,496.84 | 0.0000927 | $ | 242.55 | |||||||||||||||
Total Offering Amounts | $ | 2,616,496.84 | $ | 242.55 | ||||||||||||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||||||
Net Fee Due | $ | 242.55 |
(1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock issuable upon the conversion or exercise, as applicable, of the Preferred Stock and Warrants offered hereby also include an indeterminate number of additional shares of common stock as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions. |
(2) | With respect to the shares of common stock offered by the selling stockholders, estimated at $0.2256 per share, the average of the high and low prices as reported on The Nasdaq Capital Market on August 26, 2022, for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act. |